Bryan Sun
Associate Professor, Dermatology
School of Medicine
School of Medicine
Director of Faculty Development in Research, Dermatology
School of Medicine
School of Medicine
B.S., Stanford, 1997, Biological Sciences
B.A., Stanford, 1997, English
M.D., Harvard Medical School, 2008
Ph.D., Harvard Medical School, 2006
B.A., Stanford, 1997, English
M.D., Harvard Medical School, 2008
Ph.D., Harvard Medical School, 2006
Email: sunb8@uci.edu
University of California, Irvine
847 Medical Sciences Rd
Room 3150A
Irvine, CA 92697
847 Medical Sciences Rd
Room 3150A
Irvine, CA 92697
Research Interests
epidermis; epidermal differentiation; skin; skin biology; organoids; stem cell biology; cellular differentiation; noncoding RNAs; enhancers; noncoding genome; mosaicism; genodermatoses; genetic disease
Websites
Academic Distinctions
Phi Beta Kappa
Research Abstract
Genetic disruption of skin development and differentiation is responsible for diseases that affect >20% of the population. In the Sun Lab, we use primary skin cells, human skin organoids, and xenograft models to decipher the genomic regulators and molecular pathways that govern skin development and disease. We integrate laboratory and patient-originated approaches. Some of our current interests include:
• Determining the function of non-protein coding genomic elements in the skin with a focus on non-coding RNAs (ncRNAs).
• Discovering new disease-causing genetic mutations in the coding and non-coding genome and understanding their molecular mechanisms. We have a particular interest in subjects with genetic mosaic skin conditions.
• Understanding the genetic and epigenetic impacts of medications on the skin.
• Determining the function of non-protein coding genomic elements in the skin with a focus on non-coding RNAs (ncRNAs).
• Discovering new disease-causing genetic mutations in the coding and non-coding genome and understanding their molecular mechanisms. We have a particular interest in subjects with genetic mosaic skin conditions.
• Understanding the genetic and epigenetic impacts of medications on the skin.
Awards and Honors
2026 - Elected Member, American Society for Clinical Investigation
2022 - American Society for Clinical Investigation Young Investigator's Award
2021 - NIH Director's DP2 New Innovator Award
2020 - LEO Foundation Research Award
2019 - Doris Duke Charitable Foundation Clinician Scientist Award
2017 - Dermatology Foundation Research Award
2016 - Eugene A. Bauer Outstanding Physician-Scientist Award, Stanford University
2012 - Ruth Kirschstein NRSA F32 Postdoctoral Fellowship, NIH
2008 - Shipley Prize for Excellence in Research, Harvard Medical School
1998 - Award of Merit, National Human Genome Research Institute
1997 - Dean's Award for Public Service, Stanford University
2022 - American Society for Clinical Investigation Young Investigator's Award
2021 - NIH Director's DP2 New Innovator Award
2020 - LEO Foundation Research Award
2019 - Doris Duke Charitable Foundation Clinician Scientist Award
2017 - Dermatology Foundation Research Award
2016 - Eugene A. Bauer Outstanding Physician-Scientist Award, Stanford University
2012 - Ruth Kirschstein NRSA F32 Postdoctoral Fellowship, NIH
2008 - Shipley Prize for Excellence in Research, Harvard Medical School
1998 - Award of Merit, National Human Genome Research Institute
1997 - Dean's Award for Public Service, Stanford University
Publications
ORIGINAL RESEARCH
1. Hacia JG, Edgemon K, Sun B, Stern D, Fodor SP, Collins FS. Two color hybridization analysis using high density oligonucleotide arrays and energy transfer dyes. Nucleic Acids Res 26 (1998): 3865–6.
2. Hacia JG, Sun B, Hunt N, Edgemon K, Mosbrook D, Robbins C, Fodor SP, Tagle DA, Collins FS. Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res 8 (1998): 1245–58.
3. Hacia JG, Fan JB, Ryder O, Jin L, Edgemon K, Ghandour G, Mayer RA, Sun B, Hsie L, Robbins CM, Brody LC, Wang D, Lander ES, Lipshutz R, Fodor SP, Collins FS. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet 22 (1999): 164–7.
4. Boumil RM, Ogawa Y, Sun BK, Huynh KD, and Lee JT. Differential methylation of Xite and CTCF sites in Tsix mirrors the pattern of X-inactivation choice in mice. Mol and Cell Biol 26 (2006): 2109–17.
5. Sun BK, Deaton AM, and Lee JT. A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization. Mol Cell 21 (2006): 617–28
6. Ogawa Y, Sun BK, Lee JT. Intersection of the RNA interference and X-inactivation pathways. Science 320 (2008): 1336-41.
7. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322 (2008): 750–6.
8. Sun BK and H Tsao. Small RNAs in development and disease. J Am Acad Dermatol 59 (2008): 725–37.
9. Sun BK, Saggini A, Sarin KY, Kim J, Benjamin L, LeBoit P, and PA Khavari. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol 133 (2013): 824–837.
10. Sarin KY, Sun BK, Bangs CD, Cherry A, Swetter SM, Kim J, and PA Khavari. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus. JAMA Dermatology 149 (2013): 1077–81.
11. Sun BK, Boxer LD, Ransohoff JD, Siprashvili Z, Qu K, Lopez-Pajares V, Hollmig ST, and PA Khavari. CALML5 is a ZNF750 and TINCR-induced protein that binds Stratifin to regulate epidermal differentiation. Genes Dev 29 (2015): 2225-30.
12. Pyles MN, Nkansah N, and BK Sun. Patient satisfaction in dermatologic care delivered by a medical student-run free clinic. J Am Acad Dermatol 74 (2016): 1265–67.
13. Sun BK, Wang H, Kim J, Chen JK, Sun L, Zhang Y, and SM Swetter. Mutational profile of primary dermal melanoma: A case series. J Am Acad Dermatol 75 (2016): 1263–65.
14. Cai E*, Sun BK*, Chiang A, Rogers A, Bernet L, Cheng B, Teng J, Rieger KE, and KY Sarin. Postzygotic mutations in beta-actin are associated with Becker’s nevus and Becker’s nevus syndrome. J Invest Dermatol 137 (2017): 1795–1798. *co-first author
15. Ishii MA, Miyachi K, Cheng B, and BK Sun. Aging-associated decline of epidermal PSMD8 contributes to declining skin function. J Invest Dermatol 138 (2018): 976–978.
16. Eichenfield DZ, Cotter D, Thorson J, Hinds B, and BK Sun. Agminated blue nevus with a GNAQ mutation: A case report and review of the literature. J Cutan Pathol 46 (2019): 130–133.
17. Chen SY, Ishii MA, Cheng B, Otten ABC, and BK Sun. HOPX is a ZNF750 target that promotes epidermal differentiation. J Invest Dermatol 139 (2019): 2039–2042.
18. Cai P, Otten ABC, Cheng B, Ishii MA, Zhang W, Huang B, Qu K, and BK Sun. A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis. Genome Res 30 (2020): 22–34.
19. Wang L, Cheng B, Ju Q, and BK Sun. AhR regulates peptidoglycan-induced inflammatory gene expression in human keratinocytes. J Innate Immun 14 (2022): 124–134.
20. Wang L, Yang M, Wang X, Cheng B, Ju Q, Eichenfield DZ, and BK Sun. Glucocorticoids promote CCL20 expression in keratinocytes. Br J Dermatol 185 (2021): 1200–1208.
21. Ahn GS, Acuff K, Sun BK, and SL Baxter. Spectrum severe ocular complications following dupilumab exposure: A perspective from the ophthalmology clinic. J Am Acad Dermatol 87 (2022): 469–472.
22. Gupta D, Menon S, Criqui MH, and BK Sun. Temporal association of reduced serum vitamin D with COVID-19 infection: Two single-institution case–control studies. Nutrients 14 (2022): 2757.
23. Ikediobi O, Sui JY, Kellogg C, Roso Mares A, Takashima S, Bertini JD, Daniels B, Hinds B, and BK Sun. A pilot study using immunohistochemical staining to characterize dihydropyrimidine dehydrogenase (DPD) expression in keratinocyte neoplasms. JAAD Int 11 (2023): 90–91.
24. Otten ABC, Amarbayar O, Cai P, Cheng B, Qu K, and BK Sun. The long noncoding RNA PRANCR is associated with alternative splicing of fibronectin-1 in keratinocytes. J Invest Dermatol 143 (2023): 1825–1830.
25. Tai-Seale M, Baxter S, Millen M, Cheung M, Zisook S, Celebi J, Polston G, Sun BK, et al. Association of physician burnout with perceived EHR work stress and potentially actionable factors. J Am Med Inform Assoc 30 (2023): 1665-1672.
26. Takashima S, Sun W, Otten ABC, Cai P, Peng SI, Tong E, Bui J, Mai M, Amarbayar O, Cheng B, Odango RJ, Li Z, Qu K, and BK Sun. Alternative mRNA splicing events and regulators in epidermal differentiation. Cell Reports 43 (2024): 113814.
27. Dong S, Zhang S, Park H, De La Rosa J, Al-Nabti A, Pham VX, Cedeno A, Toledo I, Jallorina A, Laborada J, Sun BK, Wang R, and G Hightower. Artificial intelligence tools may be superior to traditional approaches for translating patient handouts: A pilot study. JAAD Int 16 (2024): 252–53.
28. Cheng B, Peng SI, Jia YY, Tong E, Atwood SX, and BK Sun. Comprehensive secretome profiling and CRISPR screen identifies SFRP1 as a key inhibitor of epidermal progenitor proliferation. Cell Death Dis 16 (2025): 360.
29. Yuen C, Chu E, O’Connell R, Sun BK, Vyas R, Zheng M, Elliott E, and C Xiao. Selumetinib in adult neurofibromatosis 1 with plexiform neurofibroma. Pharmaceuticals 18 (2025): 1039.
30. Roso Mares A, Perez IA, Schairer D, and BK Sun. Glomulin and cerebral cavernous malformations 2 protein-like mutations in an extensive blaschkoid glomunovenous malformation with polydactyly. JAAD Case Rep 63 (2025): 139-42.
31. Sun P, Kraus CN, Zhao W, Xu J, Suh S, Nguyen Q, Jia Y, Nair A, Oakes M, Tinoco R, Shiu J, Sun BK, Elsensohn A, Atwood SX, Nie Q, and X Dai. Spatial and single-cell transcriptomics reveal keratinocytes as key players in vulvar lichen sclerosus pathogenesis. J Invest Dermatol 146 (2026): 678-698.
REVIEW ARTICLES & BOOK CHAPTERS
1. Anguera MC, Sun BK, Xu N, Lee JT. X-chromosome kiss and tell: how the Xs go their separate ways. Cold Spring Harbor Symp Quant Biol 71 (2006): 429–37.
2. Sun BK and JT Lee. X-chromosome inactivation. Chapter in: Encyclopedic Reference in Genomics and Proteomics in Molecular Medicine. Heidelberg: Springer Berlin. 2006.
3. Sun BK and H Tsao. X-chromosome inactivation and skin disease. J Invest Dermatol 128 (2008): 2753–9.
4. Sun BK, Siprashvili Z, and PA Khavari. Advances in skin grafting and treatment of cutaneous wounds. Science 346 (2014): 941-945.
5. Otten ABC and BK Sun. Research Techniques Made Simple: CRISPR Genetic Screens. J Invest Dermatol 140 (2020): 723-728.
6. Sui JY, Eichenfield DZ, and BK Sun. The role of enhancers in psoriasis and atopic dermatitis. Br J Dermatol 190 (2023): 10-19.
7. Roso-Mares A, Andujar I, Diaz Corpas T, and BK Sun. Non-coding RNAs as skin disease biomarkers, molecular signatures, and therapeutic targets. Hum Genet 143 (2024): 801–812.
8. Jia BB, Sun BK, Lee EY, and B Ren. Emerging techniques in spatial multiomics: Fundamental principles and applications to dermatology. J Invest Dermatol 145 (2025): 1017-1032.
1. Hacia JG, Edgemon K, Sun B, Stern D, Fodor SP, Collins FS. Two color hybridization analysis using high density oligonucleotide arrays and energy transfer dyes. Nucleic Acids Res 26 (1998): 3865–6.
2. Hacia JG, Sun B, Hunt N, Edgemon K, Mosbrook D, Robbins C, Fodor SP, Tagle DA, Collins FS. Strategies for mutational analysis of the large multiexon ATM gene using high-density oligonucleotide arrays. Genome Res 8 (1998): 1245–58.
3. Hacia JG, Fan JB, Ryder O, Jin L, Edgemon K, Ghandour G, Mayer RA, Sun B, Hsie L, Robbins CM, Brody LC, Wang D, Lander ES, Lipshutz R, Fodor SP, Collins FS. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet 22 (1999): 164–7.
4. Boumil RM, Ogawa Y, Sun BK, Huynh KD, and Lee JT. Differential methylation of Xite and CTCF sites in Tsix mirrors the pattern of X-inactivation choice in mice. Mol and Cell Biol 26 (2006): 2109–17.
5. Sun BK, Deaton AM, and Lee JT. A transient heterochromatic state in Xist preempts X inactivation choice without RNA stabilization. Mol Cell 21 (2006): 617–28
6. Ogawa Y, Sun BK, Lee JT. Intersection of the RNA interference and X-inactivation pathways. Science 320 (2008): 1336-41.
7. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322 (2008): 750–6.
8. Sun BK and H Tsao. Small RNAs in development and disease. J Am Acad Dermatol 59 (2008): 725–37.
9. Sun BK, Saggini A, Sarin KY, Kim J, Benjamin L, LeBoit P, and PA Khavari. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome. J Invest Dermatol 133 (2013): 824–837.
10. Sarin KY, Sun BK, Bangs CD, Cherry A, Swetter SM, Kim J, and PA Khavari. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus. JAMA Dermatology 149 (2013): 1077–81.
11. Sun BK, Boxer LD, Ransohoff JD, Siprashvili Z, Qu K, Lopez-Pajares V, Hollmig ST, and PA Khavari. CALML5 is a ZNF750 and TINCR-induced protein that binds Stratifin to regulate epidermal differentiation. Genes Dev 29 (2015): 2225-30.
12. Pyles MN, Nkansah N, and BK Sun. Patient satisfaction in dermatologic care delivered by a medical student-run free clinic. J Am Acad Dermatol 74 (2016): 1265–67.
13. Sun BK, Wang H, Kim J, Chen JK, Sun L, Zhang Y, and SM Swetter. Mutational profile of primary dermal melanoma: A case series. J Am Acad Dermatol 75 (2016): 1263–65.
14. Cai E*, Sun BK*, Chiang A, Rogers A, Bernet L, Cheng B, Teng J, Rieger KE, and KY Sarin. Postzygotic mutations in beta-actin are associated with Becker’s nevus and Becker’s nevus syndrome. J Invest Dermatol 137 (2017): 1795–1798. *co-first author
15. Ishii MA, Miyachi K, Cheng B, and BK Sun. Aging-associated decline of epidermal PSMD8 contributes to declining skin function. J Invest Dermatol 138 (2018): 976–978.
16. Eichenfield DZ, Cotter D, Thorson J, Hinds B, and BK Sun. Agminated blue nevus with a GNAQ mutation: A case report and review of the literature. J Cutan Pathol 46 (2019): 130–133.
17. Chen SY, Ishii MA, Cheng B, Otten ABC, and BK Sun. HOPX is a ZNF750 target that promotes epidermal differentiation. J Invest Dermatol 139 (2019): 2039–2042.
18. Cai P, Otten ABC, Cheng B, Ishii MA, Zhang W, Huang B, Qu K, and BK Sun. A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis. Genome Res 30 (2020): 22–34.
19. Wang L, Cheng B, Ju Q, and BK Sun. AhR regulates peptidoglycan-induced inflammatory gene expression in human keratinocytes. J Innate Immun 14 (2022): 124–134.
20. Wang L, Yang M, Wang X, Cheng B, Ju Q, Eichenfield DZ, and BK Sun. Glucocorticoids promote CCL20 expression in keratinocytes. Br J Dermatol 185 (2021): 1200–1208.
21. Ahn GS, Acuff K, Sun BK, and SL Baxter. Spectrum severe ocular complications following dupilumab exposure: A perspective from the ophthalmology clinic. J Am Acad Dermatol 87 (2022): 469–472.
22. Gupta D, Menon S, Criqui MH, and BK Sun. Temporal association of reduced serum vitamin D with COVID-19 infection: Two single-institution case–control studies. Nutrients 14 (2022): 2757.
23. Ikediobi O, Sui JY, Kellogg C, Roso Mares A, Takashima S, Bertini JD, Daniels B, Hinds B, and BK Sun. A pilot study using immunohistochemical staining to characterize dihydropyrimidine dehydrogenase (DPD) expression in keratinocyte neoplasms. JAAD Int 11 (2023): 90–91.
24. Otten ABC, Amarbayar O, Cai P, Cheng B, Qu K, and BK Sun. The long noncoding RNA PRANCR is associated with alternative splicing of fibronectin-1 in keratinocytes. J Invest Dermatol 143 (2023): 1825–1830.
25. Tai-Seale M, Baxter S, Millen M, Cheung M, Zisook S, Celebi J, Polston G, Sun BK, et al. Association of physician burnout with perceived EHR work stress and potentially actionable factors. J Am Med Inform Assoc 30 (2023): 1665-1672.
26. Takashima S, Sun W, Otten ABC, Cai P, Peng SI, Tong E, Bui J, Mai M, Amarbayar O, Cheng B, Odango RJ, Li Z, Qu K, and BK Sun. Alternative mRNA splicing events and regulators in epidermal differentiation. Cell Reports 43 (2024): 113814.
27. Dong S, Zhang S, Park H, De La Rosa J, Al-Nabti A, Pham VX, Cedeno A, Toledo I, Jallorina A, Laborada J, Sun BK, Wang R, and G Hightower. Artificial intelligence tools may be superior to traditional approaches for translating patient handouts: A pilot study. JAAD Int 16 (2024): 252–53.
28. Cheng B, Peng SI, Jia YY, Tong E, Atwood SX, and BK Sun. Comprehensive secretome profiling and CRISPR screen identifies SFRP1 as a key inhibitor of epidermal progenitor proliferation. Cell Death Dis 16 (2025): 360.
29. Yuen C, Chu E, O’Connell R, Sun BK, Vyas R, Zheng M, Elliott E, and C Xiao. Selumetinib in adult neurofibromatosis 1 with plexiform neurofibroma. Pharmaceuticals 18 (2025): 1039.
30. Roso Mares A, Perez IA, Schairer D, and BK Sun. Glomulin and cerebral cavernous malformations 2 protein-like mutations in an extensive blaschkoid glomunovenous malformation with polydactyly. JAAD Case Rep 63 (2025): 139-42.
31. Sun P, Kraus CN, Zhao W, Xu J, Suh S, Nguyen Q, Jia Y, Nair A, Oakes M, Tinoco R, Shiu J, Sun BK, Elsensohn A, Atwood SX, Nie Q, and X Dai. Spatial and single-cell transcriptomics reveal keratinocytes as key players in vulvar lichen sclerosus pathogenesis. J Invest Dermatol 146 (2026): 678-698.
REVIEW ARTICLES & BOOK CHAPTERS
1. Anguera MC, Sun BK, Xu N, Lee JT. X-chromosome kiss and tell: how the Xs go their separate ways. Cold Spring Harbor Symp Quant Biol 71 (2006): 429–37.
2. Sun BK and JT Lee. X-chromosome inactivation. Chapter in: Encyclopedic Reference in Genomics and Proteomics in Molecular Medicine. Heidelberg: Springer Berlin. 2006.
3. Sun BK and H Tsao. X-chromosome inactivation and skin disease. J Invest Dermatol 128 (2008): 2753–9.
4. Sun BK, Siprashvili Z, and PA Khavari. Advances in skin grafting and treatment of cutaneous wounds. Science 346 (2014): 941-945.
5. Otten ABC and BK Sun. Research Techniques Made Simple: CRISPR Genetic Screens. J Invest Dermatol 140 (2020): 723-728.
6. Sui JY, Eichenfield DZ, and BK Sun. The role of enhancers in psoriasis and atopic dermatitis. Br J Dermatol 190 (2023): 10-19.
7. Roso-Mares A, Andujar I, Diaz Corpas T, and BK Sun. Non-coding RNAs as skin disease biomarkers, molecular signatures, and therapeutic targets. Hum Genet 143 (2024): 801–812.
8. Jia BB, Sun BK, Lee EY, and B Ren. Emerging techniques in spatial multiomics: Fundamental principles and applications to dermatology. J Invest Dermatol 145 (2025): 1017-1032.
Grants
NIH R01 AR079992 | "Role of the FAAH-OUT Locus in Cutaneous Wound Healing" | Goal: Understand how the FAAH-OUT locus deletion mediates accelerated wound healing in humans | Role: PI | 09/2022 - 06/2027 | $2,300,000
NIH DP2 HG012441 | "Insights to Noncoding Disease Variants using Mosaic Diseases" | Goal: study subjects with mosaic genetic conditions to identify and functionally characterize causative noncoding disease variants | Role: PI | 10/2021 - 06/2026 | $2,377,000
P30 Seed Grant | "Alternative mRNA Isoforms in Human Epidermis" | Goal: Apply long-read, single-cell RNA sequencing to human epidermis to identify full-length isoform representation across human epidermal differentiation | Role: PI | 07/2025 - 06/2026 | $30,000
Doris Duke Charitable Foundation | "Noncoding Genetic Regulators of Skin Disease" | Goal: Identify and characterize the potential roles of noncoding functional elements in skin diseases | Role: PI | 2019 - 2023 | $550,000
LEO Foundation | "Genetic and Epigenetic Mechanisms of Steroid-Related Skin Inflammation" | Goal: Define the repertoire of genomic and epigenetic targets of steroids in human skin | Role: PI | 2021 - 2023 | $467,000
NIH R03 AR075844 | "CRISPR Screen to Identify Novel Secreted Epidermal Regulators" | Goal: Identify novel secreted regulators using CRISPR screens of keratinocyte proliferation and differentiation | Role: PI | 2019 - 2022 | $157,500
National Psoriasis Foundation | "Long Noncoding RNAs in Psoriasis Pathogenesis" | Goal: Evaluate the role of four candidate long noncoding RNAs in keratinocyte hyperproliferation | Role: PI | 2020 - 2021 | $75,000
National Eczema Association | "Long Non-coding RNAs in the Pathogenesis of Eczema" | Goal: Understand the role of a novel long noncoding RNA in eczema progression | Role: PI | 2019 - 2020 | $75,000
SunPharma / Society for Investigative Dermatology Award | "Long Non-coding RNA function in squamous cell carcinoma" | Goal: Understand the role of a novel long noncoding RNAs in SCC pathogenesis | Role: PI | 2018 - 2019 | $50,000
American Skin Association Grant | "Impact of Becker's Nevus-Associated ACTB Mutations on Hedgehog Signaling" | Goal: Understand the role of beta actin mutations in pathogenesis of Becker's nevus | Role: PI | 2018 | $15,000
NIH / NIAMS K08 AR067853 | "Secreted Regulators of Epidermal Homeostasis" | Goal: Define secreted factors produced in keratinocytes that impact the development and health of human skin | Role: PI | 2016 - 2021 | $910,548
Professional Societies
American Academy of Dermatology
Society for Investigative Dermatology
American Society for Clinical Investigation
Other Experience
UCI MSTP Admissions and Recruitment Steering Subcommittee
UC Irvine 2026—Pres
UC Irvine 2026—Pres
UCI T32 Skin Biology Training Grant, Steering Committee
UC Irvine 2026—Pres
UC Irvine 2026—Pres
UCI Medical Scientist Training Program, Admissions Committee Standing Member
UC Irvine 2025—Pres
UC Irvine 2025—Pres
UCI Cellular and Molecular Biosciences PhD Program, Admissions Committee
UC Irvine 2025—Pres
UC Irvine 2025—Pres
Space Allocation Advisory Committee (SRAAC), Standing Member
UCI Health 2024—Pres
UCI Health 2024—Pres
Associate Director
UCI ICTS K12 Program 2024—Pres
UCI ICTS K12 Program 2024—Pres
Graduate Programs
Dermatology
Research Centers
Center for Epigenetics and Metabolism
Link to this profile
https://faculty.uci.edu/profile/?facultyId=7212
https://faculty.uci.edu/profile/?facultyId=7212
Last updated
06/02/2026
06/02/2026